BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2931490)

  • 21. [The importance of screening for hepatitis B surface antigens in pregnancy].
    Mancal P; Podrouzek P; Kozlová J; Labohá J
    Cas Lek Cesk; 1989 Nov; 128(48):1517-20. PubMed ID: 2611846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates.
    Assateerawatt A; Tanphaichitr VS; Suvatte V; In-ngarm L
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):89-93. PubMed ID: 1839654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of perinatal transmission of hepatitis B virus (HBV): a comparison of two prophylactic schedules.
    Wheeley SM; Jackson PT; Boxall EH; Tarlow MJ; Gatrad AR; Anderson J; Bissenden J
    J Med Virol; 1991 Nov; 35(3):212-5. PubMed ID: 1839553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of immune serum globulin to prevent hepatitis B virus infection in infants born to HBsAg-positive mothers.
    Tong MJ; McPeak CM; Thursby MW; Schweitzer IL; Henneman CE; Ledger WJ
    Gastroenterology; 1979 Mar; 76(3):535-9. PubMed ID: 85562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of hepatitis B vaccine alone or in combination with hepatitis B immunoglobulin for immunoprophylaxis of perinatal hepatitis B infection.
    Sehgal A; Sehgal R; Gupta I; Bhakoo ON; Ganguly NK
    J Trop Pediatr; 1992 Oct; 38(5):247-51. PubMed ID: 1433451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants.
    Ayoola EA; Johnson AO
    Int J Gynaecol Obstet; 1987 Aug; 25(4):297-301. PubMed ID: 2887464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunogenicity and harmlessness in the newborn of a vaccine (GenHevac B) containing the antigens S and pre-S2].
    Tron F; Soulié JC; Goudeau A; Devillier P; Saliou P
    Bull Soc Pathol Exot; 1991; 84(5 Pt 5):901-5. PubMed ID: 1840243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early predictor of the efficacy of immunoprophylaxis against perinatal hepatitis B transmission: analysis of prophylaxis failure.
    Lin HH; Chang MH; Chen DS; Sung JL; Hong KH; Young YC; Yang KH; Lee TY
    Vaccine; 1991 Jun; 9(6):457-60. PubMed ID: 1832257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mass protection program of perinatal hepatitis B virus infection in Japan and impact of an optional booster vaccination on its efficacy.
    Tajiri H; Kozaiwa K; Harada T; Ozaki Y; Miki K; Shimizu K; Okada S
    Acta Paediatr Jpn; 1991 Jun; 33(3):323-6. PubMed ID: 1785327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term immunoprophylaxis of hepatitis B surface antigen carrier in infants born to hepatitis B surface antigen positive mothers using plasma derived vaccine.
    Theppisai U; Thanuntaseth C; Chiewsilp P; Siripoonya P
    Asia Oceania J Obstet Gynaecol; 1989 Jun; 15(2):111-5. PubMed ID: 2527026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.
    Stroffolini T; Pasquini P; Mele A
    Vaccine; 1989 Apr; 7(2):152-4. PubMed ID: 2526420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of booster HB vaccine in preventing hepatitis B virus infection from mother to child.
    Kunitomi T; Ikeda M; Oda M; Yamada G; Eguchi K; Ubuka K; Morita H; Kurashige T
    Acta Paediatr Jpn; 1989 Dec; 31(6):669-73. PubMed ID: 2533789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B vaccination of newborn infants: clinical study of new vaccine formulation and dose regimen.
    Lee KS; Lee H; Moon SJ; Choi KJ; Kim KH; Kim CW; Chung WS; Choi TY
    Hepatology; 1987; 7(5):941-5. PubMed ID: 2958400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B vaccination of relatives of hepatitis B virus DNA positive carriers: an experience with plasma-derived vaccine.
    Craxì A; Vinci M; Almasio P; Pagliaro L
    Eur J Epidemiol; 1989 Mar; 5(1):65-9. PubMed ID: 2523316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission.
    Stevens CE; Taylor PE; Tong MJ; Toy PT; Vyas GN; Nair PV; Weissman JY; Krugman S
    JAMA; 1987 May; 257(19):2612-6. PubMed ID: 2952812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined immunoprophylaxis in the prevention of perinatal transmission of hepatitis B and hepatitis D virus infections in Saudi children.
    Bahakim H; Ramia S; Kurbaan K
    Ann Trop Paediatr; 1990; 10(2):139-43. PubMed ID: 1699476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of hepatitis B vaccination on infants born to carriers without HBe antigenemia.
    Shin K; Nagai Y; Ono I; Sumasaki R; Takita H
    Acta Paediatr Jpn; 1989 Apr; 31(2):177-9. PubMed ID: 2516697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The control of hepatitis B virus infection with vaccine in Japanese nursery schools.
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H
    Am J Epidemiol; 1987 Sep; 126(3):474-9. PubMed ID: 2956878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of perinatal transmission of the hepatitis B virus. Outcome of infants in a community prevention program.
    Niu MT; Targonski PV; Stoll BJ; Albert GP; Margolis HS
    Am J Dis Child; 1992 Jul; 146(7):793-6. PubMed ID: 1496944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection of cord blood leukocytes.
    Shen HD; Choo KB; Wu TC; Ng HT; Han SH
    J Med Virol; 1987 Jul; 22(3):211-6. PubMed ID: 2957463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.